5.2. Analysis.
Comparison 5 Non‐comparative studies: proportion of participants withdrawn from methylphenidate treatment due to serious adverse events, Outcome 2 Proportion of participants withdrawn from methylphenidate treatment due to adverse events of unknown severity.
| Proportion of participants withdrawn from methylphenidate treatment due to adverse events of unknown severity | |
|---|---|
| Study | |
| Altin 2013 | 4/204 |
| Arnold 2004 | 4/89 |
| Arnold 2010 | 4/171 |
| Atzori 2009 | 17/189 |
| Chou 2012b | 15/296 |
| Dodangi 2011 | 2/15 |
| Döpfner 2011a, OBSEER | 26/822 |
| Findling 2009 | 51/326 |
| Kim 2015b | 8/143 |
| Kordon 2011 | 53/598 |
| Kratochvil 2002 | 5/44 |
| Lee 2009 | 28/144 |
| Lee 2012 | 1/93 |
| Maia 2008 | 3/39 |
| Mayes 1994 | 2/69 |
| McCracken 2016 | 1/69 |
| Mohammadi 2009 | 6/30 |
| Remschmidt 2005 | 16/89 |
| Steele 2006 | 6/73 |
| Yang 2004 | 2/25 |
| Yang 2012 | 15/130 |
| Yildiz 2010 | 3/50 |